Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 Inhibitors
Clinical trial NCT05460481 · UNKNOWN
Trial details
- NCT number
- NCT05460481
- Sponsor
- Hunan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-12
- Primary completion
- 2023-06-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.